Seòmar agus comataidhean

Health boards can take a range of actions in response to any breach of terms by a pharmacy contractor. Community pharmacy contractors are required to meet the Terms of Service as set out in Schedule 1 of the National Health Service (Pharmaceutical Services) (Scotland) Regulation 2009. Should, in the opinion of the Health Board, a community pharmacy contractor breach the Terms of Service, they can consider taking any appropriate action in line with the noted Regulation and the National Health Service (Discipline Committees) (Scotland) Regulations 2006.

I refer the member to the answer to question S6W-10043 on 24 August 2022. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

The Scottish Government has no immediate plans to amend the current National Health Service ((Pharmaceutical Services) (Scotland) Regulations 2009. The Scottish Government is committed to review the current contractual arrangements in line with the recommendations set out in the Achieving Excellence in Pharmaceutical Care strategy.

The General Pharmaceutical Council (GPhC) is the UK's independent regulator for pharmacists, pharmacy technicians and pharmacy premises and ensures pharmacy services are delivered in accordance with the required standards. There are no plans to instruct the Care Inspectorate to regulate this sector.

Any large infrastructure organisation that provides an essential service requires significant access to cash to maintain its activities and to respond to unforeseen events. Scottish Water’s cash balances each year are largely a function of when the business borrows from the Scottish Government relative to when capital investments are made; unlike similar infrastructure businesses, Scottish Water does not have access to any other credit facilities. Some of that capital investment will be on projects not delivered in the preceding regulatory period. Furthermore, at any point in time Scottish Water has on-going investment projects and hence has contractual commitments with its delivery partners and it must ensure it has sufficient funds to meet those contractual commitments. At 31 March 2022 Scottish Water had contractual capital commitments of £455.6m and at 31 March 2021 this figure was £541.4m, hence my comments in the Scottish Parliament on 18 May 2022 that Scottish Water's cash balance is ''substantially allocated at any time to investment projects''.

I refer the member to the answer to question S6W-11011 on 4 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-11011 on 4 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Ministers’ charging policies and Objectives for the water industry are clearly set out in the key framework documents that can be found on the Scottish Government’s website. Current circumstances facing the industry, indeed the country at large, are undoubtedly challenging and the Scottish Government will maintain regular dialogue with Scottish Water to support the continued delivery of all of Ministers’ Objectives over the current regulatory period. The affordability of charges is a matter for Scottish Water’s Board to consider alongside the requirement to meet its other statutory obligations. WICS has no powers to require a particular outcome in the charge setting process beyond setting the charge caps which are established to protect customers.

NHS Scotland and the Scottish Government remains focused on delivering high-quality care in the safest possible way for patients of all cancer types, including blood cancers.

The National Cancer Plan, published on 9 December 2020, includes actions to improve access to treatments for all cancers.

The Covid-19 National Cancer Medicines Advisory Group (NCMAG) was established to oversee interim governance arrangements for cancer medicines in response to the impact of Covid-19 on the health service. These arrangements include two new medicines approved for use with patients with leukaemia, a type of blood cancer.

We have established the Scottish Cancer Network, which is a dedicated national resource to support and facilitate a ‘Once for Scotland’ approach to cancer services. Its aim is to enable equitable access to care and treatment across Scotland.

Lastly, an updated Framework for Effective Cancer Management was published on 3 December 2021. It supports clinicians and NHS managers to drive improvements in cancer pathways, including blood cancers, providing Health Boards with the tools to effectively manage cancer patients and ultimately recover waiting times.

I refer the member to the answer to S6W-10989 on 3 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .